Loading…

COVID-19? Let me see your hands

During the first wave of the COVID 19 pandemic, a patient with anti-synthetase syndrome (ASS) was misdiagnosed as having bilateral severe acute respiratory syndrome coronavirus 2 pneumonia on admission. A comprehensive clinical evaluation would have led to the correct diagnosis earlier, as he had so...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of the Royal College of Physicians of Edinburgh 2023-12, Vol.53 (4), p.269-271
Main Authors: Bernal-Bello, David, Lara-Montes, Celia, Jaenes-Barrios, Beatriz
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During the first wave of the COVID 19 pandemic, a patient with anti-synthetase syndrome (ASS) was misdiagnosed as having bilateral severe acute respiratory syndrome coronavirus 2 pneumonia on admission. A comprehensive clinical evaluation would have led to the correct diagnosis earlier, as he had some data consistent with ASS on both physical examination and laboratory tests that were initially overlooked. In addition, a malignant lesion in the colon was found on screening for underlying malignancy. In this context, ASS has been considered a low-risk subgroup for cancer among idiopathic inflammatory myopathies. However, this should be interpreted cautiously and should not lead to neglect of adequate cancer screening adjusted for age, sex and other potential risk factors.
ISSN:1478-2715
2042-8189
DOI:10.1177/14782715231206530